Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population-Reference-Cited by-同舟云学术

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Published:2015-06-10 Issue:6 Volume:10 Page:e0124653
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shah Nigam H.,LePendu Paea,Bauer-Mehren Anna,Ghebremariam Yohannes T.,Iyer Srinivasan V.,Marcus Jake,Nead Kevin T.,Cooke John P.,Leeper Nicholas J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Proton pump inhibitor side effects and drug interactions: much ado about nothing?;RD Madanick;Cleve Clin J Med,2011

2. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users;MH Katz;Arch Intern Med,2010

3. U.S. Food and Drug Administration (FDA). FDA Drug Safety Podcast for Healthcare Professionals: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). Available: http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm245455.htm, 2009.

4. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee;Lancet,1996

5. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome;PM Ho;JAMA: the journal of the American Medical Association,2009

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of gastric acid secretion increase oxidative stress and matrix metalloproteinase-2 activity leading to vascular remodeling;Molecular and Cellular Biochemistry;2024-02-01

2. Proton pump inhibitor induced hypomagnesemia and mortality: mediation analyses in the Diabetes Care System cohort;2023-12-21

3. Hypomagnesemia, Cardiovascular disease and other adverse effects in long term users of Proton pump inhibitors.;2023-12-20

4. Heartburn’s Hidden Impact: A Narrative Review Exploring Gastroesophageal Reflux Disease (GERD) as a Cardiovascular Disease Risk Factor;Journal of Clinical Medicine;2023-11-29

5. Proton Pump Inhibitors Use is Associated with Increased Liver Steatosis: A Nationally Representative Study;2023-08-31